Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7862]

The combination makes the difference: New therapeutic approach against breast cancer

The combination makes the difference: New therapeutic approach against breast cancer

Ribociclib offers more life in the first-line setting for postmenopausal HR+/HER2- advanced breast cancer patients

Ribociclib offers more life in the first-line setting for postmenopausal HR+/HER2- advanced breast cancer patients

New study reviews anti-cancer activity of sustained release capsaicin formulations

New study reviews anti-cancer activity of sustained release capsaicin formulations

Tumours on withdrawal: Amino acid deficiency shrinks childhood tumours

Tumours on withdrawal: Amino acid deficiency shrinks childhood tumours

Scientists proposed a carrier for targeted chemotherapy drug

Scientists proposed a carrier for targeted chemotherapy drug

A promising combination therapy for triple-negative breast cancer

A promising combination therapy for triple-negative breast cancer

Gene mutations that contribute to head and neck cancer also provide “precision” treatment targets

Gene mutations that contribute to head and neck cancer also provide “precision” treatment targets

Researchers shed light on why a certain plant virus is so powerful at fighting cancer

Researchers shed light on why a certain plant virus is so powerful at fighting cancer

Tislelizumab plus chemo improved overall survival as first-line treatment for advanced oesophageal cancer in phase III study

Tislelizumab plus chemo improved overall survival as first-line treatment for advanced oesophageal cancer in phase...

Palmitoylation, a new target for anti-cancer drugs

Palmitoylation, a new target for anti-cancer drugs

More from ecancer